Cite
HARVARD Citation
Rakocevic, G. et al. (2018). Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. Neurology. 5 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rakocevic, G. et al. (2018). Obinutuzumab, a potent anti–B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. Neurology. 5 (4), p. . [Online].